查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1957375

2026年盧克血液分離術全球市場報告

Leukapheresis Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，白血球分離療法的市場規模呈現顯著成長。預計該市場規模將從2025年的720.2億美元成長至2026年的777億美元，複合年成長率（CAGR）為7.9%。過去幾年的成長主要歸因於血液疾病的增加、癌症研究計畫的擴展、血液中心血球分離術的普及、離心技術的進步以及臨床研究經費的增加。

預計未來幾年白血球分離療法市場將維持強勁成長，到2030年市場規模將達到1,042.7億美元，複合年成長率（CAGR）為7.6%。預測期內的成長要素包括CAR-T療法和細胞療法的進步、免疫學研究投入的增加、個人化醫療需求的成長、生物製藥生產的擴張以及自動化血球分離技術的進步。預測期內的主要趨勢包括：白血球分離技術在細胞和基因治療中的應用日益廣泛、腫瘤免疫療法需求的成長、自動化血球分離系統的應用範圍擴大、白血球分離技術在臨床研究中的應用日益廣泛，以及出於患者安全考慮，人們對一次性血球分離試劑盒的興趣日益濃厚。

預計未來幾年，自體免疫疾病盛行率的不斷上升將推動白血球分離療法市場的成長。自體免疫疾病是指免疫系統錯誤地攻擊自身健康組織的疾病。兒童時期接觸微生物的機會減少以及現代環境因素正在破壞免疫平衡，導致此類疾病的增加。白血球分離療法透過選擇性地清除導致免疫系統攻擊自身組織的有害白血球來幫助控制自體免疫疾病。例如，根據美國線上數位平台GetValue.co預測，到2025年9月，自體免疫疾病預計將影響全球3%至10%的人口，約6億至8億人。因此，自體免疫疾病盛行率的上升趨勢正在推動白血球分離療法市場的擴張。

白血球分離療法市場的主要企業正致力於研發創新技術，例如符合GMP標準的白血球包裝，以提高細胞療法生產的品質和效率。符合GMP標準的白血球分離療法衍生產品，嚴格按照良好生產規範（GMP）標準生產，確保所收集細胞具有高活性和功能性，可用於治療。例如，2024年11月，美國生物技術公司Sangain Biosciences宣布推出符合GMP標準的白血球包裝“LeukoCer”，旨在簡化工作流程並加速細胞療法的開發。 LeukoCer提供符合嚴格GMP標準的新鮮、完整或半包裝的高品質原料，使研究人員能夠更有效率地推進研究並將新的細胞療法推向市場。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球血液分離術市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 永續性、氣候技術、循環經濟
  • 主要趨勢
    • 擴大白血球分離和血液採集方法在細胞和基因治療的應用
    • 腫瘤學領域對免疫療法的需求不斷成長
    • 自動化血液分離系統的應用日益普及
    • 擴大臨床研究中白血球分離血液採集的範圍
    • 人們對以病人安全為優先的一次性血漿分離術試劑盒的興趣日益濃厚。

第5章 終端用戶產業市場分析

  • 醫院及輸血中心
  • 血液成分供應商和血站
  • 製藥和生物技術公司
  • 學術研究機構
  • 細胞治療生產設施

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球盧克血液分離市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球盧克血漿分離術市場規模、對比及成長率分析
  • 全球血液分離術市場表現：規模與成長，2020-2025年
  • 全球血液分離術市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按類型進行血液分離術
  • 粒細胞分離術、淋巴球分離術、單核細胞分離術
  • 依產品
  • 白血球分離器、離心機、膜分離器、白血球分離用拋棄式
  • 透過使用
  • 用於研究目的，癌症研究，免疫學研究，治療目的，血液疾病，自體免疫疾病及其他用途。
  • 最終用戶
  • 血液成分供應商和血液中心、學術研究機構、製藥和生物技術公司、醫院和輸血中心
  • 依類型細分：粒細胞分離術
  • 嗜中性白血球分離術、嗜酸性粒細胞分離術、嗜鹼性球分離術
  • 依類型進行亞分選：淋巴球分離術
  • T細胞分離術、B細胞分離術、自然殺手（NK）細胞分離術
  • 依類型細分：單核細胞分離術
  • 經典單核細胞、非經典單核細胞、中間單核細胞

第10章 區域與國別分析

  • 全球盧克血液分離市場：依地區分類，歷史資料及預測，2020-2025年、2025-2030年、2035年
  • 全球盧克血液分離市場：依國家分類，歷史資料及預測，2020-2025年、2025-2030年、2035年

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 盧克血液分離術市場：競爭格局與市場佔有率，2024 年
  • 盧克血液分離術市場：公司估值矩陣
  • 盧克血液分離術市場：公司簡介
    • Fresenius Kabi
    • Grifols SA
    • Terumo BCT Inc.
    • Nikkiso Co.
    • Haemonetics Corporation

第37章 其他大型企業和創新企業

  • Macopharma, MEDICA SpA, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, Cellsep Laboratories

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年盧克血液分離術市場：提供新機會的國家
  • 2030年盧克血液分離術市場：提供新機會的細分市場
  • 2030年盧克血液分離術市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: PH5MLEUK02_G26Q1

Leukapheresis is a medical procedure in which white blood cells (leukocytes) are separated and removed from a person's blood, while the remaining components, such as red blood cells and plasma, are returned to the body. This technique is employed to treat conditions with elevated white blood cell counts or to collect specific immune cells for research or therapeutic purposes.

The primary types of leukapheresis include granulocyte, lymphocyte, and monocyte apheresis. Granulocyte apheresis selectively isolates granulocytes (a type of white blood cell) from a patient's blood for therapeutic use. Products involved include leukapheresis devices, centrifugal devices, membrane separators, and disposables. Applications cover research, cancer studies, immunology research, therapeutic treatments, hematologic disorders, autoimmune diseases, and more, and are utilized by blood component providers, blood centers, academic and research institutes, pharmaceutical and biotechnology companies, as well as hospitals and transfusion centers.

Tariffs have impacted the leukapheresis market by increasing costs for imported apheresis devices, disposable kits, and precision centrifugation components. These impacts are most evident in therapeutic and research applications, particularly in North America, Europe, and Asia-Pacific regions with high device import dependence. Increased tariffs have raised procurement costs for hospitals, blood centers, and research institutes. Positively, tariffs have encouraged regional manufacturing of leukapheresis systems and improved supply chain localization.

The leukapheresis market research report is one of a series of new reports from The Business Research Company that provides leukapheresis market statistics, including leukapheresis industry global market size, regional shares, competitors with a leukapheresis market share, detailed leukapheresis market segments, market trends and opportunities, and any further data you may need to thrive in the leukapheresis industry. This leukapheresis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The leukapheresis market size has grown strongly in recent years. It will grow from $72.02 billion in 2025 to $77.7 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to growth in hematologic disorders, expansion of cancer research programs, increasing use of apheresis in blood centers, advancements in centrifugation technologies, rising clinical research funding.

The leukapheresis market size is expected to see strong growth in the next few years. It will grow to $104.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to growth in car-t and cell-based therapies, increasing investment in immunology research, rising demand for personalized medicine, expansion of biopharmaceutical manufacturing, technological advancements in apheresis automation. Major trends in the forecast period include rising use of leukapheresis in cell and gene therapies, increasing demand for immune cell collection in oncology, growing adoption of automated apheresis systems, expansion of leukapheresis in clinical research, increasing focus on patient-safe disposable apheresis kits.

The increasing prevalence of autoimmune diseases is expected to drive the growth of the leukapheresis market in the coming years. Autoimmune diseases are conditions in which the immune system mistakenly attacks the body's own healthy tissues. Reduced microbial exposure in early life and modern environmental factors are disrupting immune balance, contributing to the rise of these disorders. Leukapheresis helps manage autoimmune diseases by selectively removing harmful white blood cells that cause the immune system to attack the body. For example, in September 2025, according to GetValue.co, a US-based online digital platform, autoimmune diseases affect an estimated 3-10% of the global population, or roughly 600-800 million people worldwide. Consequently, the growing prevalence of autoimmune diseases is fueling the expansion of the leukapheresis market.

Major companies in the leukapheresis market are focusing on innovations such as GMP-grade leukopaks to improve the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are leukapheresis-derived products processed under strict good manufacturing practice (GMP) standards, ensuring high viability and functionality of the collected cells for therapeutic use. For example, in November 2024, Sanguine Biosciences, a US-based biotechnology company, launched LeukoCer, a GMP-grade leukopak designed to streamline workflows and accelerate cell therapy development. LeukoCer provides high-quality starting materials in fresh whole or half packs, produced according to rigorous GMP standards, enabling researchers to advance their work and bring new cell therapies to market more efficiently.

In July 2023, SCTbio, a Czech Republic-based contract development and manufacturing organization, partnered with Cyto-care.eu GmbH to improve the cryopreservation process for cell therapy in Europe. The collaboration focuses on enhancing the collection, cryopreservation, quality control, and logistics of leukapheresis materials, which are essential for manufacturing advanced cell therapy products (ATMPs). Cyto-care.eu GmbH is an Austria-based company specializing in supplying cell products for biomedical research, drug discovery, and cell and gene therapy.

Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., Haemonetics Corporation, Macopharma, MEDICA S.p.A, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, Cellsep Laboratories

North America was the largest region in the leukapheresis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the leukapheresis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leukapheresis market consists of revenues earned by entities providing services such as cell collection, cell processing and storage, and custom apheresis procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The leukapheresis market also includes sales of products such as apheresis machines, centrifugal and membrane-based systems, needles & catheters, and anticoagulants and solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukapheresis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses leukapheresis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukapheresis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The leukapheresis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Apheresis Type: Granulocyte Apheresis; Lymphocyte Apheresis; Monocyte Apheresis
  • 2) By Product: Leukapheresis Devices; Centrifugal Devices; Membrane Separators; Leukapheresis Disposables
  • 3) By Application: Research Application; Cancer Research; Immunology Research; Therapeutics Application; Hematologic Disorders; Autoimmune Diseases; Other Applications
  • 4) By End User: Blood Component Providers And Blood Centers; Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Transfusion Centers
  • Subsegments:
  • 1) By Granulocyte Apheresis: Neutrophil Apheresis; Eosinophil Apheresis; Basophil Apheresis
  • 2) By Lymphocyte Apheresis: T-Cell Apheresis; B-Cell Apheresis; Natural Killer (NK) Cell Apheresis
  • 3) By Monocyte Apheresis: Classical Monocytes; Non-Classical Monocytes; Intermediate Monocytes
  • Companies Mentioned: Fresenius Kabi; Grifols S.A.; Terumo BCT Inc.; Nikkiso Co.; Haemonetics Corporation; Macopharma; MEDICA S.p.A; Caltag Medsystems Ltd.; Miltenyi Biotec; Puriblood Medical; Cytopheron Technologies; STEMCELL Technologies Inc.; Discovery Life Sciences; BioIVT LLC; StemExpress LLC; AllCells LLC; HemaCare Corporation; Key Biologics LLC; Immune Therapy Holdings AB; Cellsep Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Leukapheresis Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Leukapheresis Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Leukapheresis Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Leukapheresis Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Rising Use Of Leukapheresis In Cell And Gene Therapies
    • 4.2.2 Increasing Demand For Immune Cell Collection In Oncology
    • 4.2.3 Growing Adoption Of Automated Apheresis Systems
    • 4.2.4 Expansion Of Leukapheresis In Clinical Research
    • 4.2.5 Increasing Focus On Patient-Safe Disposable Apheresis Kits

5. Leukapheresis Market Analysis Of End Use Industries

  • 5.1 Hospitals And Transfusion Centers
  • 5.2 Blood Component Providers And Blood Center
  • 5.3 Pharmaceutical And Biotechnology Companies
  • 5.4 Academic And Research Institutes
  • 5.5 Cell Therapy Manufacturing Facilities

6. Leukapheresis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Leukapheresis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Leukapheresis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Leukapheresis Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Leukapheresis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Leukapheresis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Leukapheresis Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Leukapheresis Market Segmentation

  • 9.1. Global Leukapheresis Market, Segmentation By Apheresis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis
  • 9.2. Global Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables
  • 9.3. Global Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications
  • 9.4. Global Leukapheresis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers
  • 9.5. Global Leukapheresis Market, Sub-Segmentation Of Granulocyte Apheresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis
  • 9.6. Global Leukapheresis Market, Sub-Segmentation Of Lymphocyte Apheresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis
  • 9.7. Global Leukapheresis Market, Sub-Segmentation Of Monocyte Apheresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

10. Leukapheresis Market Regional And Country Analysis

  • 10.1. Global Leukapheresis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Leukapheresis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Leukapheresis Market

  • 11.1. Asia-Pacific Leukapheresis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Leukapheresis Market

  • 12.1. China Leukapheresis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Leukapheresis Market

  • 13.1. India Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Leukapheresis Market

  • 14.1. Japan Leukapheresis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Leukapheresis Market

  • 15.1. Australia Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Leukapheresis Market

  • 16.1. Indonesia Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Leukapheresis Market

  • 17.1. South Korea Leukapheresis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Leukapheresis Market

  • 18.1. Taiwan Leukapheresis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Leukapheresis Market

  • 19.1. South East Asia Leukapheresis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Leukapheresis Market

  • 20.1. Western Europe Leukapheresis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Leukapheresis Market

  • 21.1. UK Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Leukapheresis Market

  • 22.1. Germany Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Leukapheresis Market

  • 23.1. France Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Leukapheresis Market

  • 24.1. Italy Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Leukapheresis Market

  • 25.1. Spain Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Leukapheresis Market

  • 26.1. Eastern Europe Leukapheresis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Leukapheresis Market

  • 27.1. Russia Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Leukapheresis Market

  • 28.1. North America Leukapheresis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Leukapheresis Market

  • 29.1. USA Leukapheresis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Leukapheresis Market

  • 30.1. Canada Leukapheresis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Leukapheresis Market

  • 31.1. South America Leukapheresis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Leukapheresis Market

  • 32.1. Brazil Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Leukapheresis Market

  • 33.1. Middle East Leukapheresis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Leukapheresis Market

  • 34.1. Africa Leukapheresis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Leukapheresis Market Regulatory and Investment Landscape

36. Leukapheresis Market Competitive Landscape And Company Profiles

  • 36.1. Leukapheresis Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Leukapheresis Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Leukapheresis Market Company Profiles
    • 36.3.1. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Terumo BCT Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Nikkiso Co. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Haemonetics Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Leukapheresis Market Other Major And Innovative Companies

  • Macopharma, MEDICA S.p.A, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, Cellsep Laboratories

38. Global Leukapheresis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Leukapheresis Market

40. Leukapheresis Market High Potential Countries, Segments and Strategies

  • 40.1 Leukapheresis Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Leukapheresis Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Leukapheresis Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer